Estimation of the Direct Cost of HIV-Infected Patients in Greece on an Annual Basis

Boubouchairopoulou, N.; Athanasakis, Kostas; Chini, Maria; Mangafas, Nikos; Lazanas, M; Kyriopoulos, John

doi:10.1016/j.vhri.2014.07.005

Cited by 5 publications

(5 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…and North America [9,22,23]. In Greece, for example, 83.7% of total costs were attributable to drugs [24] in comparison with 74.9% in our study. We observed no significant difference between CDC classifications and higher costs for CDC stage 1 or for CD4 cell count.…”

Section: Discussioncontrasting

confidence: 57%

A Cost-of-Illness Study of Patients with HIV/AIDS in Bogotá, Colombia

Kuhlmann

Keaei

Conde

et al. 2017

Value in Health Regional Issues

View full text Add to dashboard Cite

HIV/AIDS represents a high societal burden in Colombia. In comparison with the gross domestic product per capita of $7,904 in 2014, the mean annual cost per patient with HIV/AIDS was 40% higher, estimated at $11,505. The largest part of the HIV/AIDS costs was attributed to drugs, followed by productivity costs. Using extrapolation, the total cost of HIV/AIDS for the Colombian society would be $1.431 billion.

show abstract

Section: Discussioncontrasting

confidence: 57%

A Cost-of-Illness Study of Patients with HIV/AIDS in Bogotá, Colombia

Kuhlmann

Keaei

Conde

et al. 2017

Value in Health Regional Issues

View full text Add to dashboard Cite

show abstract

“…Two of the studies are population based [4,5], providing the first information on the economic burden of substance abuse and several types of cancers in the Russian Federation. Other studies estimated the COI in a sample of patients with rheumatoid arthritis and its relation to disease severity [6]; the cost related to work productivity of patients with ankylosing spondylitis, rheumatoid arthritis, and psoriasis in the Czech Republic [7]; the direct cost of HIV-infected patients in Greece [8]; and a single-center study from Ghana assessing the health facility cost of Buruli ulcer wound infection [9]. Although all these studies present a cost analysis, some may not be considered traditional COI analyses because of their narrow scope.…”

mentioning

confidence: 99%

What Are the Challenges in Conducting Cost-of-Illness Studies?

Greenberg

Ibrahim

Boncz

2014

Value in Health Regional Issues

View full text Add to dashboard Cite

“…Direct costs were calculated by multiplying the annual cost for one treated HIV patient by the number of treated patients and the median treatment time. The average annual direct cost per treated patient in Greece in 2017 was €6860 [ 25 ] (This estimation contains all the health care resources consumed by HIV-infected patients in Greece).…”

Section: Methodsmentioning

confidence: 99%

Could the 2010 HIV outbreak in Athens, Greece have been prevented? A mathematical modeling study

et al. 2021

View full text Add to dashboard Cite

Introduction In 2009 and 2010, Athens, Greece experienced a hepatitis C virus (HCV) and a Human Immunodeficiency Virus (HIV) outbreak among People Who Inject Drugs (PWID), respectively. The HCV outbreak was not detected, while that of HIV was identified in 2011. The integrated HIV-interventions, launched in early 2012, managed to reduce directly the HIV incidence and indirectly the HCV incidence. This study aims to assess what would have been the course of the HIV outbreak and its associated economic consequences if the 2009 HCV outbreak had been detected and integrated interventions had been initiated 1- or 2-years earlier. Methods The model was calibrated to reproduce the observed HIV epidemiological and clinical parameters among PWID of Athens, Greece. We examined the effect of the 1- or 2-years earlier detection scenarios, the 1-year later detection, the non-detection scenario, and compared them to the status quo scenario. Results Cumulative HIV cases, under the status-quo scenario during 2009‐2019, were 1360 (90% Credible intervals: 290, 2470). If the HCV outbreak had been detected 1- or 2- years earlier, with immediate initiation of integrated interventions, 740 and 1110 HIV cases could be averted by 2019, respectively. Regarding the costs, if there was an efficient notification system to detect the HCV outbreak 1 or 2 years earlier, 35.2–53.2 million euros could be saved compared to the status quo by 2019. Conclusions If the HCV outbreak had been detected and promptly addressed, the HIV outbreak would have been prevented and 35.2–53.2 million euros could have been saved.

show abstract

Estimation of the Direct Cost of HIV-Infected Patients in Greece on an Annual Basis

Abstract: The direct cost of HIV infection per patient increased as CD4 T lymphocytes decreased. The largest part of expenses was attributed to antiretroviral therapy, followed by laboratory tests/imaging studies, hospitalization, and finally outpatient visits.

Cited by 5 publications

References 20 publications

A Cost-of-Illness Study of Patients with HIV/AIDS in Bogotá, Colombia

A Cost-of-Illness Study of Patients with HIV/AIDS in Bogotá, Colombia

What Are the Challenges in Conducting Cost-of-Illness Studies?

Could the 2010 HIV outbreak in Athens, Greece have been prevented? A mathematical modeling study

Contact Info

Product

Resources

About